Literature DB >> 16616922

Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding.

Georges Tabarani1, José J Reina, Christine Ebel, Corinne Vivès, Hugues Lortat-Jacob, Javier Rojo, Franck Fieschi.   

Abstract

DC-SIGN (dendritic cell-specific ICAM-3 grabbing non-integrin) is a C-type lectin receptor of dendritic cells and is involved in the initial steps of numerous infectious diseases. Surface plasmon resonance has been used to study the affinity of a glycodendritic polymer with 32 mannoses, to DC-SIGN. This glycodendrimer binds to DC-SIGN surfaces in the submicromolar range. This binding depends on a clustered organization of DC-SIGN mimicking its natural organization as microdomain in the dendritic cells plasma membrane. Moreover, this compound inhibits DC-SIGN binding to the HIV glycoprotein gp120 with an IC50 in the micromolar range and therefore can be considered as a potential antiviral drug.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616922     DOI: 10.1016/j.febslet.2006.03.061

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Non-carbohydrate inhibitors of the lectin DC-SIGN.

Authors:  M Jack Borrok; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

2.  DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain.

Authors:  Georges Tabarani; Michel Thépaut; David Stroebel; Christine Ebel; Corinne Vivès; Patrice Vachette; Dominique Durand; Franck Fieschi
Journal:  J Biol Chem       Date:  2009-06-05       Impact factor: 5.157

Review 3.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

4.  Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.

Authors:  Russell Clayton; Janee Hardman; Celia C LaBranche; Katherine D McReynolds
Journal:  Bioconjug Chem       Date:  2011-09-06       Impact factor: 4.774

5.  Synthesis of LewisX-O-Core-1 threonine: A building block for O-linked LewisX glycopeptides.

Authors:  Mohammed Y R Sardar; Venkata R Krishnamurthy; Simon Park; Appi Reddy Mandhapati; Walter J Wever; Dayoung Park; Richard D Cummings; Elliot L Chaikof
Journal:  Carbohydr Res       Date:  2017-10-10       Impact factor: 2.104

6.  Inhibition binding studies of glycodendrimer-lectin interactions using surface plasmon resonance.

Authors:  Kristian H Schlick; Mary J Cloninger
Journal:  Tetrahedron       Date:  2010-07-17       Impact factor: 2.457

7.  Multivalent Cluster Nanomolecules for Inhibiting Protein-Protein Interactions.

Authors:  Elaine A Qian; Yanxiao Han; Marco S Messina; Heather D Maynard; Petr Král; Alexander M Spokoyny
Journal:  Bioconjug Chem       Date:  2019-09-23       Impact factor: 4.774

Review 8.  Nanoparticle-based drug delivery to the vagina: a review.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  J Control Release       Date:  2014-05-14       Impact factor: 9.776

Review 9.  Nanotechnology and the treatment of HIV infection.

Authors:  Raveen Parboosing; Glenn E M Maguire; Patrick Govender; Hendrik G Kruger
Journal:  Viruses       Date:  2012-04-10       Impact factor: 5.048

10.  Glycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding mode.

Authors:  Eric Chabrol; Alessandra Nurisso; Antoine Daina; Emilie Vassal-Stermann; Michel Thepaut; Eric Girard; Romain R Vivès; Franck Fieschi
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.